Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer.
Saved in:
| Title: | Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer. |
|---|---|
| Authors: | Petrova MP; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Eneva MI; Hospital Pharmacy 'Nadezhda' Sofia, Bulgaria., Arabadjiev JI; Department of Medical Oncology, MHAT 'Tokuda', Sofia, Bulgaria., Conev NV; Clinic of Medical Oncology, UMHAT 'St. Marina', Varna, Bulgaria., Dimitrova EG; Clinic of Medical Oncology, UMHAT 'St. Marina', Varna, Bulgaria., Koynov KD; Department of Medical Oncology, MHAT 'Serdika', Sofia, Bulgaria., Karanikolova TS; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Valev SS; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Gencheva RB; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Zhbantov GA; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Ivanova AI; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Sarbianova II; Department of Intensive Care Unit, MHAT 'Nadezhda', Sofia, Bulgaria., Timcheva CV; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Donev IS; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria. |
| Source: | Bioscience trends [Biosci Trends] 2020 Mar 16; Vol. 14 (1), pp. 48-55. Date of Electronic Publication: 2020 Feb 04. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1881-7823 (Electronic) Linking ISSN: 18817815 NLM ISO Abbreviation: Biosci Trends Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
